Table 1. Patient demographics.
| Odense University Hospital cohort | ||||
|---|---|---|---|---|
| CD (n = 72) | UC (n = 60) | IBS (n = 22) | Healthy donors (n = 24) | |
| Gender | ||||
| • Male, (%) | 27 (37) | 29 (48) | 2 (9) | 21 (88) |
| • Female, (%) | 45 (63) | 31 (52) | 20 (91) | 3 (12) |
| Age mean years; (range) | 35.8 (15–76) | 37.3 (21–70) | 34.4 (16–75) | 41.3 (19–60] |
| BMI mean kg/m2; (range) | 25.8 (16.2–45.1) | 26 (18.6–36.4) | 26.3 (18.1–43.3) | N/A |
| Smoking | ||||
| • Yes, (%) | 40 (56) | 35 (58) | 9 (41) | N/A |
| • No, (%) | 32 (44) | 25 (42) | 13 (59) | N/A |
| Use of immunosuppressants* | ||||
| • Yes, (%) | 30 (42) | 32 (53) | 0 (0) | N/A |
| • No, (%) | 42 (58) | 28 (47) | 22 (100) | N/A |
| Bowel resection prior to inclusion | 20 | 0 | 0 | 0 |
| Disease activity | CDAI score | St. marks score | ||
| • Active disease, (%) | 37 (51) | 54 (90) | N/A | N/A |
| • Remission, (%) | 30 (42) | 6 (10) | ||
Abbreviations: CD; Crohn’s disease, UC; ulcerative colitis, IBS; irritable bowel disease, N/A; not available.
The total overview of patients demographics can be reviewed in a previously published article[14].
*use of immunosupressants/glucocorticoids.